LeMaitre Vascular, Inc. (LMAT)
108.99
+0.81
(+0.75%)
USD |
NASDAQ |
Mar 02, 13:09
LeMaitre Vascular Research and Development Expense (TTM) : 14.14M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| OraSure Technologies, Inc. | 40.96M |
| PROCEPT BioRobotics Corp. | 68.07M |
| Abbott Laboratories | 2.89B |
| Accuray, Inc. | 44.10M |
| Plus Therapeutics, Inc. | 7.624M |